Importantly, loss of the mammalian ortholog of sut-2, MSUT2, was also shown to reduce insoluble tau pathology and mitigate cognitive decline in transgenic models of tauopathy [30, 82]. The gene discussed is ZC3H14; the disease is tauopathy.